Risperidone
SIGMA/R3030 - ≥98% (HPLC), powder
Synonym: R 64,766
CAS Number: 106266-06-2
Empirical Formula (Hill Notation): C23H27FN4O2
Molecular Weight: 410.48
MDL Number: MFCD00274576
Linear Formula: C23H27FN4O2
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to off-white |
| form | powder |
| InChI | 1S/C23H27FN4O2/c1-15-18(2 |
| InChI key | RAPZEAPATHNIPO-UHFFFAOYSA |
| originator | Johnson & Johnson |
| Quality Level | 100 ![]() |
| SMILES string | CC1=C(CCN2CCC(CC2)c3noc4c |
| solubility | DMSO: ≥5 mg/mL |
| storage temp. | room temp |
| Application: | Risperidone has been used: • to study its effects on bone formation and differentiation • to investigate the relationship between risperidone (RIS) dosages and RIS plasma levels in autism spectrum disorder (ASD) pediatric patients • to reverse induced schizophrenia-like behavior in mice |
| Biochem/physiol Actions: | Risperidone is an antipsychotic; serotonin-dopamine antagonist. |
| Features and Benefits: | This compound was developed by Johnson & Johnson . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| General description: | Risperidone is a benzisoxazole derivative. It functions as an antagonist for dopamine D2, histamine H1 and α1 and α2 adrenergic receptors. Risperidone is used to treat schizophrenia, bipolar disorder and autism. |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS06 |
| Signal word | Danger |
| Hazard statements | H301 |
| Precautionary statements | P301 + P310 |
| Hazard Codes | T |
| Risk Statements | 25 |
| Safety Statements | 28-36-45 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | room temp |
| UNSPSC | 12352200 |


